rno-miR-665 targets BCL2L1 (Bcl-xl) and increases vulnerability to propofol in developing astrocytes.
Propofol exerts a cytotoxic influence over immature neurocytes. Our previous study revealed that clinically relevant doses of propofol accelerated apoptosis of primary cultured astrocytes of developing rodent brains via rno-miR-665 regulation. However, the role of rno-miR-665 during the growth spurt of neonatal rodent brains in vivo is still uncertain. Post-natal day 7 (P7) rats received a single injection of propofol 30 mg/kg intraperitoneally (i.p.), and neuroapoptosis of hippocampal astrocytes was analyzed by immunofluorescence and scanning electron microscopy. The differential expression of rno-miR-665, BCL2L1 (Bcl-xl), and cleaved caspase 3 (CC3) was surveyed by qRT-PCR and western blotting. In addition, the utility of A-1155463, a highly potent and BCL2L1-selective antagonist, was aimed to assess the contribution of BCL2L1 for neuroglial survival. Following the intraventricular injection of lentivirus rno-miR-665, neuroprotection was detected by 5-point scale measurement. The single dose of propofol 30 mg/kg triggered dose-dependent apoptosis of developing hippocampal astrocytes. Meanwhile, propofol triggered both rno-miR-665 and CC3, and depressed BCL2L1, which was predicted as one target gene of rno-miR-665. Combination treatment with A-1155463 and propofol induced lower mRNA and protein levels of BCL2L1 and more CC3 activation than propofol treatment alone in vivo. The lentivirus-mediated knockdown of rno-miR-665 elevated BCL2L1 and attenuated CC3 levels, whereas up-regulation of rno-miR-665 suppressed BCL2L1 and induced CC3 expression in vivo. More importantly, rno-miR-665 antagomir infusion improved neurological outcomes of pups receiving propofol during the brain growth spurt. Rno-miR-665, providing a potential target for alternative therapeutics for pediatric anesthesia, is susceptible to propofol by negatively targeting antiapoptotic BCL2L1. Relatively little is known about the association between exposure of astrocytes to brief propofol anaesthesia and risk for impairment. Here, it revealed that propofol-related neurotoxicity of neonatal astrocytes was under rno-miR-665 regulation during the brain growth spurt. Rno-miR-665 might act as a clinically alternative therapeutic target for treatment of neurological disorders in peadiatric anesthesia or sedation with propofol in future.
Department of Anesthesiology, the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China.
Wen-Chong
WC
Sun
Department of Anesthesiology, the First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China.
Ling
L
Pei
D000818:Animals; D017209:Apoptosis / Q000187:drug effects; D001253:Astrocytes / Q000187:drug effects* / Q000378:metabolism; D052160:Benzothiazoles / Q000494:pharmacology; D002478:Cells, Cultured; D006624:Hippocampus / Q000378:metabolism; D007546:Isoquinolines / Q000494:pharmacology; D008297:Male; D035683:MicroRNAs / Q000235:genetics*; D055495:Neurogenesis / Q000187:drug effects*; D009474:Neurons / Q000378:metabolism; D015742:Propofol / Q000494:pharmacology*; D017207:Rats, Sprague-Dawley; D015854:Up-Regulation / Q000187:drug effects; D051020:bcl-X Protein / Q000235:genetics*
C000603579:A-1155463; C494813:Bcl2l1 protein, rat; D052160:Benzothiazoles; D007546:Isoquinolines; C000620785:MIRN665 microRNA, rat; D035683:MicroRNAs; D051020:bcl-X Protein; D015742:Propofol
BCL2L1; apoptosis; cleaved caspase 3; lentivirus; propofol; rno-miR-665